Elite Pharmaceuticals Inc (ELTP)

[dr_lowenstein]

allow me to explain how savvy pharma investors evaluate stocks:

To summarize:
1. based on current performance and fundaments. In thus case, the revenues are shrinking and the gross margins are abysmal for a generics company
2. Past performance, did management do what they said they were going to do? in this case, of course it is another failing grade
3. Future potential, nasdaq stocks with no revenues are often mentioned but what is not understood is that these stocks are viewed to have POTENTIAL- again another failing grade for elite